BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23226752)

  • 1. Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis.
    Ao R; Wang YH; Li RW; Wang ZR
    Exp Ther Med; 2012 Nov; 4(5):933-937. PubMed ID: 23226752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis.
    Wen F; Zhou Y; Wang W; Hu QC; Liu YT; Zhang PF; Du ZD; Dai J; Li Q
    Ann Oncol; 2013 Jan; 24(1):171-8. PubMed ID: 22898039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.
    Wu Z; Ouyang J; He Z; Zhang S
    Eur J Cancer; 2012 Aug; 48(12):1791-8. PubMed ID: 22542974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study.
    Ishibashi K; Okada N; Miyazaki T; Sano M; Ishida H
    Int J Clin Oncol; 2010 Feb; 15(1):82-7. PubMed ID: 20108160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.
    Knijn N; Tol J; Koopman M; Werter MJ; Imholz AL; Valster FA; Mol L; Vincent AD; Teerenstra S; Punt CJ
    Eur J Cancer; 2011 Feb; 47(3):369-74. PubMed ID: 21067912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.
    Wang DS; Wang ZQ; Chen G; Peng JW; Wang W; Deng YH; Wang FH; Zhang JW; Liang HL; Feng F; Xie CB; Ren C; Jin Y; Shi SM; Fan WH; Lu ZH; Ding PR; Wang F; Xu RH; Li YH
    Cancer Med; 2020 Jan; 9(1):151-159. PubMed ID: 31724334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.
    Gamelin L; Boisdron-Celle M; Delva R; Guérin-Meyer V; Ifrah N; Morel A; Gamelin E
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4055-61. PubMed ID: 15217938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and Magnesium Infusions for the Prevention of Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review.
    Jordan B; Jahn F; Beckmann J; Unverzagt S; Müller-Tidow C; Jordan K
    Oncology; 2016; 90(6):299-306. PubMed ID: 27169552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial.
    Liu Y; Zhu G; Han L; Liu J; Ma T; Yu H
    Evid Based Complement Alternat Med; 2013; 2013():541217. PubMed ID: 24324514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of compound porcine cerebroside and ganglioside on neurotoxicity caused by oxaliplatin chemotherapy: preliminary results.
    Zhang YL; Wei LY; Yao HW; Jin L; Wang J; Zhang J; Zhao XM; Cai J; Bai ZG; Deng W
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5441-5448. PubMed ID: 31298397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
    Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y
    Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
    Khattak MA
    Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer.
    Zhang X; Chen H; Lu Y; Xu C; Yao W; Xu L; Zhang R; Zhang L; Yao Q
    Medicine (Baltimore); 2020 Dec; 99(50):e23564. PubMed ID: 33327312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.
    Kurniali PC; Luo LG; Weitberg AB
    Oncology (Williston Park); 2010 Mar; 24(3):289-92. PubMed ID: 20394142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab-induced hypomagnesaemia aggravates peripheral sensory neurotoxicity caused by oxaliplatin.
    Kono T; Satomi M; Asama T; Ebisawa Y; Chisato N; Suno M; Karasaki H; Furukawa H; Matsubara K
    J Gastrointest Oncol; 2010 Dec; 1(2):97-101. PubMed ID: 22811813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radix Astragali-Based Chinese Herbal Medicine for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis.
    Deng B; Jia L; Cheng Z
    Evid Based Complement Alternat Med; 2016; 2016():2421876. PubMed ID: 27795728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
    Muto O; Ando H; Ono T; Itagaki H; Kobayashi Y; Onuki M; Akashi T; Tanaka Y; Hanaoka T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):579-81. PubMed ID: 17431344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
    Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
    Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial.
    Bondad N; Boostani R; Barri A; Elyasi S; Allahyari A
    J Oncol Pharm Pract; 2020 Oct; 26(7):1575-1582. PubMed ID: 32063109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.